468 related articles for article (PubMed ID: 17038643)
1. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
2. Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.
Huber SA; Sartini D
J Virol; 2005 Mar; 79(5):2659-65. PubMed ID: 15708985
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.
Huber SA; Mortensen A; Moulton G
J Virol; 1996 May; 70(5):3039-44. PubMed ID: 8627781
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.
Huber SA; Graveline D; Born WK; O'Brien RL
J Virol; 2001 Jul; 75(13):5860-9. PubMed ID: 11390587
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells.
Huber SA
Virology; 2008 Sep; 378(2):292-8. PubMed ID: 18586295
[TBL] [Abstract][Full Text] [Related]
6. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.
Huber SA; Sartini D; Exley M
J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
Gangaplara A; Massilamany C; Brown DM; Delhon G; Pattnaik AK; Chapman N; Rose N; Steffen D; Reddy J
Clin Immunol; 2012 Sep; 144(3):237-49. PubMed ID: 22854287
[TBL] [Abstract][Full Text] [Related]
8. Cross-regulation of T regulatory-cell response after coxsackievirus B3 infection by NKT and γδ T cells in the mouse.
Liu W; Moussawi M; Roberts B; Boyson JE; Huber SA
Am J Pathol; 2013 Aug; 183(2):441-9. PubMed ID: 23746656
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
[TBL] [Abstract][Full Text] [Related]
10. Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells.
Huber SA; Born W; O'Brien R
Microbes Infect; 2005 Mar; 7(3):537-43. PubMed ID: 15777711
[TBL] [Abstract][Full Text] [Related]
11. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
Huber SA; Moraska A; Choate M
J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
[TBL] [Abstract][Full Text] [Related]
12. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy.
Huber SA; Budd RC; Rossner K; Newell MK
Ann N Y Acad Sci; 1999; 887():181-90. PubMed ID: 10668474
[TBL] [Abstract][Full Text] [Related]
15. T cells expressing the Vgamma1 T-cell receptor enhance virus-neutralizing antibody response during coxsackievirus B3 infection of BALB/c mice: differences in male and female mice.
Huber S; Sartini D
Viral Immunol; 2005; 18(4):730-9. PubMed ID: 16359239
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
17. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis.
Huber SA
Immunology; 2009 Aug; 127(4):567-76. PubMed ID: 19604307
[TBL] [Abstract][Full Text] [Related]
18. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
19. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.
Massilamany C; Gangaplara A; Reddy J
Int J Cardiol; 2014 Dec; 177(2):330-339. PubMed ID: 25449464
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
